A Study of ICP-022 in Patients With R/R DLBCL

Clinical trial NCT04438005 · COMPLETED

Trial details

NCT number: NCT04438005
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2020-05-07
Primary completion: 2021-11-05
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.